Botondtól Penke

Q: What Schools Are Affiliated With Botondtól Penke

Botondtól Penke is affiliated with the following schools: University of Szeged, University of Toronto

Botondtól Penke's AcademicInfluence.com Rankings

Botondtól Penke

Biology

#12630

World Rank

#16120

Historical Rank

Molecular Biology

#2070

World Rank

#2102

Historical Rank

Neuroscience

#2132

World Rank

#2192

Historical Rank

biology Degrees

Download Badge

Biology

Botondtól Penke's Degrees

Masters Biology Eötvös Loránd University
Bachelors Biology Eötvös Loránd University

Similar Degrees You Can Earn

Why Is Botondtól Penke Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Botondtól Penke's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Amyloid β-Induced Neuronal Hyperexcitability Triggers Progressive Epilepsy (2009) (530)
A new acid hydrolysis method for determining tryptophan in peptides and proteins. (1974) (504)
Role of the Toll-Like Receptor 4 in Neuroinflammation in Alzheimer’s Disease (2007) (460)
Antisera to gamma-aminobutyric acid. I. Production and characterization using a new model system. (1985) (350)
LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide. (2005) (339)
TLR2 Is a Primary Receptor for Alzheimer’s Amyloid β Peptide To Trigger Neuroinflammatory Activation (2012) (329)
The LPS receptor (CD14) links innate immunity with Alzheimer's disease (2004) (316)
Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice (2006) (301)
Antisera to gamma-aminobutyric acid. II. Immunocytochemical application to the central nervous system. (1985) (285)
β‐Amyloid neurotoxicity is mediated by a glutamate‐triggered excitotoxic cascade in rat nucleus basalis (2000) (281)
Docosahexaenoic Acid Reduces Amyloid β Production via Multiple Pleiotropic Mechanisms* (2011) (192)
Amyloid β‐peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease (2004) (172)
Method for measuring neurotoxicity of aggregating polypeptides with the MTT assay on differentiated neuroblastoma cells (2003) (161)
The cocaine-induced elevation of plasma corticosterone is mediated by endogenous corticotropin-releasing factor (CRF) in rats (1992) (134)
Binding sites of amyloid beta-peptide in cell plasma membrane and implications for Alzheimer's disease. (2004) (126)
Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease. (2004) (120)
Mechanisms of ß-Amyloid Neurotoxicity: Perspectives of Pharmacotherapy (2000) (118)
Immunohistochemical visualization of a metabotropic glutamate receptor. (1993) (115)
Functionalization of gold nanoparticles with amino acid, beta-amyloid peptides and fragment. (2010) (113)
Decreased serum and red blood cell kynurenic acid levels in Alzheimer's disease (2007) (112)
Serotonin-immunoreactive cells in the superior cervical ganglion of the rat. Evidence for the existence of separate serotonin- and catecholamine-containing small ganglionic cells (1981) (110)
Interactions of Pathological Hallmark Proteins (2011) (110)
β-Amyloid(Phe(SO3H)24)25–35 in rat nucleus basalis induces behavioral dysfunctions, impairs learning and memory and disrupts cortical cholinergic innervation (1998) (109)
Neuroprotective effect of developmental docosahexaenoic acid supplement against excitotoxic brain damage in infant rats (2003) (109)
Neuroprotective approaches in experimental models of β-Amyloid neurotoxicity: Relevance to Alzheimer's disease (1999) (101)
Further analysis of the effects of cholecystokinin octapeptides on avoidance behaviour in rats. (1984) (101)
Stepwise dynamics of epitaxially growing single amyloid fibrils (2008) (98)
A modified, optimized kinetic photometric assay for the determination of blood coagulation factor XIII activity in plasma. (2000) (95)
Kynurenine metabolism in multiple sclerosis (2005) (93)
Chronic Corticosterone Administration Dose‐Dependently Modulates Aβ(1–42)− and NMDA‐Induced Neurodegeneration in Rat Magnocellular Nucleus Basalis (2000) (87)
Non‐fibrillar β‐amyloid abates spike‐timing‐dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors (2006) (86)
Elevated levels of inflammatory biomarkers in the cerebrospinal fluid after coronary artery bypass surgery are predictors of cognitive decline (2006) (86)
The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases (2017) (83)
Overexpression of Hsp27 ameliorates symptoms of Alzheimer's disease in APP/PS1 mice (2013) (83)
Comparative studies with somatostatin and cysteamine in different behavioral tests on rats (1984) (80)
Membrane translocation of penetratin and its derivatives in different cell lines (2003) (79)
Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice. (1981) (78)
9 – Immunocytochemical Localization of Noradrenaline, Adrenaline and Serotonin (1983) (78)
Reversible Mechanical Unzipping of Amyloid β-Fibrils* (2005) (75)
Kynurenine metabolism in plasma and in red blood cells in Parkinson's disease (2005) (75)
N-Methyl- d -Aspartate Receptor Antagonist MK-801 and Radical Scavengers Protect Cholinergic Nucleus Basalis Neurons against β-Amyloid Neurotoxicity (1999) (74)
β-Amyloid and the Pathomechanisms of Alzheimer’s Disease: A Comprehensive View (2017) (74)
Effects of nocturnal intraperitoneal administration of cholecystokinin in rats: simultaneous increase in sleep, increase in EEG slow-wave activity, reduction of motor activity, suppression of eating, and decrease in brain temperature (1988) (74)
β-Amyloid pathology in the entorhinal cortex of rats induces memory deficits: Implications for Alzheimer’s disease (2007) (74)
Cholinotoxic effects of β-amyloid(1–42) peptide on cortical projections of the rat nucleus basalis magnocellularis (1995) (74)
β-Amyloid (1–42) peptide impairs blood-brain barrier function after intracarotid infusion in rats (1998) (74)
In silico study of full-length amyloid beta 1-42 tri- and penta-oligomers in solution. (2009) (71)
β-Amyloid(1–42) affects cholinergic but not parvalbumin-containing neurons in the septal complex of the rat (1995) (71)
Subacute NO generation induced by Alzheimer's β‐amyloid in the living brain: reversal by inhibition of the inducible NO synthase (2000) (70)
Heat Shock Proteins and Autophagy Pathways in Neuroprotection: From Molecular Bases to Pharmacological Interventions (2018) (68)
In vitro model of neurotoxicity of Aβ 1–42 and neuroprotection by a pentapeptide: irreversible events during the first hour (2004) (67)
Enhancement of NMDA responses by &bgr;-amyloid peptides in the hippocampus in vivo (2004) (65)
Pentapeptide amides interfere with the aggregation of beta-amyloid peptide of Alzheimer's disease. (2002) (65)
Role of endogenous corticotropin-releasing factor in mediation of neuroendocrine and behavioral responses to cholecystokinin octapeptide sulfate ester in rats. (1993) (64)
Antisera to y-Aminobutyric Acid. (1985) (60)
Altered Functional Protein Networks in the Prefrontal Cortex and Amygdala of Victims of Suicide (2012) (60)
Investigation of penetratin peptides. Part 2. In vitro uptake of penetratin and two of its derivatives (2005) (58)
Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology. (2011) (55)
Dysfunction of Endoplasmic Reticulum (ER) and Mitochondria (MT) in Alzheimer's Disease: The Role of the ER-MT Cross-Talk. (2015) (55)
Mechanical manipulation of Alzheimer’s amyloid β1–42 fibrils (2006) (55)
New small-size peptides possessing antifungal activity. (2010) (53)
Beta-amyloid peptide-induced blood-brain barrier disruption facilitates T-cell entry into the rat brain. (2003) (53)
Oligomerization and Conformational Change Turn Monomeric β-Amyloid and Tau Proteins Toxic: Their Role in Alzheimer’s Pathogenesis (2020) (53)
Controlled in situ preparation of Aβ(1–42) oligomers from the isopeptide “iso-Aβ(1–42)”, physicochemical and biological characterization (2010) (52)
Tenascin-C deficiency ameliorates Alzheimer's disease-related pathology in mice (2013) (51)
β-Amyloid-Induced Cholinergic Denervation Correlates with Enhanced Nitric Oxide Synthase Activity in Rat Cerebral Cortex: Reversal by NMDA Receptor Blockade (1998) (51)
Functional Recovery of Cholinergic Basal Forebrain Neurons under Disease Conditions: Old Problems, New Solutions? (2002) (50)
Synthesis of Aβ[1‐42] and its derivatives with improved efficiency (2007) (50)
Special lipid-based diets alleviate cognitive deficits in the APPswe/PS1dE9 transgenic mouse model of Alzheimer's disease independent of brain amyloid deposition. (2014) (49)
Docosahexaenoic acid reduces amyloid-β induced toxicity in cells of the neurovascular unit. (2013) (48)
Critical role of endogenous corticotropin-releasing factor (CRF) in the mediation of the behavioral action of cocaine in rats. (1992) (48)
Increased serum butyrylcholinesterase activity in type IIb hyperlipidaemic patients. (2004) (47)
Synthesis of potent heptapeptide analogues of cholecystokinin. (1984) (46)
Impact of haloperidol and risperidone on gene expression profile in the rat cortex (2005) (46)
Immunohistochemical characterization of monoamine-containing neurons in the central nervous system by antibodies to serotonin and noradrenalin. A study in the rat and the lamprey (Lampetra fluviatilis). (1981) (46)
Solid-Phase Synthesis of Peptide Amides on a Polystyrene Support Using Fluorenylmethoxycarbonyl Protecting Groups (1987) (45)
Pre-treatment and post-treatment with alpha-tocopherol attenuates hippocampal neuronal damage in experimental cerebral hypoperfusion. (2007) (45)
Modulation of passive avoidance behaviour by cholecystokinin octapeptides in rats (1981) (45)
Divergent effects of Aβ1–42 on ionotropic glutamate receptor-mediated responses in CA1 neurons in vivo (2005) (44)
Studies for Improving a Rat Model of Alzheimer’s Disease: Icv Administration of Well-Characterized β-Amyloid 1-42 Oligomers Induce Dysfunction in Spatial Memory (2017) (43)
Investigation of penetratin peptides Part 1. The environment dependent conformational properties of penetratin and two of its derivatives (2002) (42)
An FT-IR study of the beta-amyloid conformation: standardization of aggregation grade. (1999) (42)
Mapping of possible binding sequences of two beta-sheet breaker peptides on beta amyloid peptide of Alzheimer's disease. (2002) (41)
β-Amyloid(1-42)-Induced Cholinergic Lesions in Rat Nucleus Basalis Bidirectionally Modulate Serotonergic Innervation of the Basal Forebrain and Cerebral Cortex (2001) (41)
A new cytotoxin specific for the target cells of corticotropin-releasing factor. (1987) (40)
Beta-amyloid-derived pentapeptide RIIGLa inhibits Abeta(1-42) aggregation and toxicity. (2004) (40)
HISTOCHEMICAL IDENTIFICATION OF ADRENALINE CONTAINING CELLS WITH SPECIAL REFERENCE TO NEURONS (1980) (39)
The Role of Lipids and Membranes in the Pathogenesis of Alzheimer's Disease: A Comprehensive View. (2018) (39)
Amyloid-β1-42 Disrupts Synaptic Plasticity by Altering Glutamate Recycling at the Synapse. (2015) (39)
Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease. (2007) (38)
A nuclear import inhibitory peptide ameliorates the severity of cholecystokinin-induced acute pancreatitis. (2005) (38)
Neuroprotective effects of a specific multi-nutrient intervention against Aβ42-induced toxicity in rats. (2011) (38)
A putative tetrapeptide antagonist prevents beta-amyloid-induced long-term elevation of [Ca2+]i in rat astrocytes. (1997) (37)
Inhibition of seizures induced by picrotoxin and electroshock by cholecystokinin octapeptides and their fragments in rats after intracerebroventricular administration (1984) (36)
The Effect of Citalopram on Gene Expression Profile of Alzheimer Lymphocytes (2004) (36)
Molecular characterization of metal-binding polypeptide domains by electrospray ionization mass spectrometry and metal chelate affinity chromatography. (1998) (35)
Potassium-dependent oriented growth of amyloid β25–35 fibrils on mica (2007) (35)
The proteasome inhibitor MG132 protects against acute pancreatitis. (2005) (35)
Penetratin and derivatives acting as antifungal agents. (2009) (34)
Highly Immunoreactive IgG Antibodies Directed against a Set of Twenty Human Proteins in the Sera of Patients with Amyotrophic Lateral Sclerosis Identified by Protein Array (2014) (34)
Harmonic vibrational frequency scaling factors for the new NDDO Hamiltonians: RM1 and PM6 (2007) (34)
Cholecystokinin interferes with the thermoregulatory effect of exogenous and endogenous opioids (1989) (33)
Gene expression profile analysis of the rat cortex following treatment with imipramine and citalopram. (2004) (33)
Pentapeptides derived from Aβ1–42 protect neurons from the modulatory effect of Aβ fibrils—an in vitro and in vivo electrophysiological study (2005) (32)
Inhibition of PKA anchoring to A-kinase anchoring proteins impairs consolidation and facilitates extinction of contextual fear memories (2008) (32)
Role of different neurotransmitter systems in the cholecystokinin octapeptide-induced anxiogenic response in rats (1997) (32)
Effects of intraventricular administration of cholecystokinin octapeptide sulfate ester and unsulfated cholecystokinin octapeptide on active avoidance and conditioned feeding behaviour of rats. (1981) (32)
Dihydropyridine Derivatives Modulate Heat Shock Responses and have a Neuroprotective Effect in a Transgenic Mouse Model of Alzheimer’s Disease (2016) (32)
Protein Folding and Misfolding, Endoplasmic Reticulum Stress in Neurodegenerative Diseases: in Trace of Novel Drug Targets. (2016) (31)
Use of antibodies to norepinephrine and epinephrine in immunohistochemistry. (1980) (31)
Iodination of Peptide Hormones and Purification of Iodinated Peptides by HPLC (1982) (31)
Identification of synaptic plasma membrane proteins co‐precipitated with fibrillar β‐amyloid peptide (2005) (29)
Combination of a modified scoring function with two-dimensional descriptors for calculation of binding affinities of bulky, flexible ligands to proteins. (2006) (29)
Protection of the blood-brain barrier by pentosan against amyloid-β-induced toxicity. (2010) (28)
In Vitro and in Vivo Nuclear Factor-κB Inhibitory Effects of the Cell-Penetrating Penetratin Peptide (2006) (28)
LPYFDa neutralizes amyloid-beta-induced memory impairment and toxicity. (2010) (28)
Intranasal Delivery of Human β-Amyloid Peptide in Rats: Effective Brain Targeting (2010) (28)
Intraneuronal β‐amyloid and its interactions with proteins and subcellular organelles (2012) (28)
Structure-activity and dose-effect relationships of the antagonism of picrotoxin-induced seizures by cholecystokinin, fragments and analogues of cholecystokinin in mice (1983) (28)
Studying the structural properties of polyalanine and polyglutamine peptides (2007) (27)
Characterization of the conformational probability of N-acetyl-phenylalanyl-NH2 by RHF, DFT, and MP2 computation and AIM analyses, confirmed by jet-cooled infrared data. (2005) (27)
Comparative study on the effects of kynurenic acid and glucosamine–kynurenic acid (2004) (27)
Specific radioimmunoassay of oxytocin in rat plasma. (1994) (27)
Tianeptine potentiates AMPA receptors by activating CaMKII and PKA via the p38, p42/44 MAPK and JNK pathways (2011) (27)
Synthesis and fluorescent labeling of beta‐amyloid peptides (2001) (27)
Endomorphin‐2, an endogenous tetrapeptide, protects against Aβ1‐42 in vitro and in vivo (2006) (27)
Pathological peptide folding in Alzheimer's disease and other conformational disorders. (2002) (27)
Propionyl-IIGL tetrapeptide antagonizes beta-amyloid excitotoxicity in rat nucleus basalis. (1999) (26)
Systems biology of Alzheimer's disease: How diverse molecular changes result in memory impairment in AD (2011) (26)
Characterization of the interaction between Aβ 1–42 and glyceraldehyde phosphodehydrogenase (2008) (26)
Acute intracerebral treatment with amyloid-beta (1–42) alters the profile of neuronal oscillations that accompany LTP induction and results in impaired LTP in freely behaving rats (2015) (26)
Protein array based interactome analysis of amyloid-β indicates an inhibition of protein translation. (2011) (26)
Effect of Lysine-28 Side-Chain Acetylation on the Nanomechanical Behavior of Alzheimer Amyloid beta25-35 Fibrils (2005) (26)
Effect of cholecystokinin octapeptide sulphate ester on brain monoamines in the rat. (1981) (26)
N-Methyl-D-aspartate receptor antagonist MK-801 and radical scavengers protect cholinergic nucleus basalis neurons against beta-amyloid neurotoxicity. (1999) (25)
β‐Amyloid Excitotoxicity in Rat Magnocellular Nucleus Basalis: Effect of Cortical Deafferentation on Cerebral Blood Flow Regulation and Implications for Alzheimer's Disease (2000) (25)
Reversible mechanical unzipping of amyloid beta-fibrils. (2005) (25)
Conformational mapping of amyloid peptides from the putative neurotoxic 25-35 region. (1994) (24)
Neurotransmitter-mediated open-field behavioral action of CGRP. (1999) (24)
A novel method for the rapid determination of beta-amyloid toxicity on acute hippocampal slices using MTT and LDH assays (2012) (24)
β-Amyloid-induced increase in the resting intracellular calcium concentration gives support to tell Alzheimer lymphocytes from control ones (2002) (24)
Proteome-wide study of endoplasmic reticulum stress induced by thapsigargin in N2a neuroblastoma cells (2013) (24)
Effect of Selective Inhibition of Potassium Channels on Vasorelaxing Response to Cromakalim, Nitroglycerin and Nitric Oxide of Canine Coronary Arteries (1995) (23)
Mitochondrial Proteome Changes Correlating with β-Amyloid Accumulation (2017) (23)
Cholecystokinin-octapeptide-induced hypothermia in rats: Dose-effect and structure-effect relationships, effect of ambient temperature, pharmacological interactions and tolerance (1987) (23)
Increased Tau Phosphorylation and Impaired Presynaptic Function in Hypertriglyceridemic ApoB-100 Transgenic Mice (2012) (22)
Comparative studies of somatostatin-14 and some of its fragments on passive avoidance behavior, open field activity and on barrel rotation phenomenon in rats (1989) (22)
Effects of Estrogen on Beta-Amyloid-Induced Cholinergic Cell Death in the Nucleus Basalis Magnocellularis (2010) (22)
Oriented epitaxial growth of amyloid fibrils of the N27C mutant β25–35 peptide (2008) (22)
Key Peptides and Proteins in Alzheimer's Disease. (2019) (22)
An intraperitoneally administered pentapeptide protects against Abeta (1-42) induced neuronal excitation in vivo. (2009) (21)
The effects of atrial natriuretic peptide on passive avoidance behaviour in rats (1991) (21)
Abeta(1-42) Enhances Neuronal Excitability in the CA1 via NR2B Subunit-Containing NMDA Receptors (2014) (21)
Comparative Studies on [Ca2+]i-Level of Fibroblasts from Alzheimer Patients and Control Individuals (2001) (21)
Somatostatin and (d-TRP8, d-CYS14)-somatostatin delay extinction and reverse electroconvulsive shock induced amnesia in rats (1986) (21)
Synthesis and conformational analysis of His-Phe-Arg-Trp-NH2 and analogues with antifungal properties. (2006) (21)
T cell recognition of the posttranslationally cleaved intersubunit region of influenza virus hemagglutinin. (1994) (21)
Aggregation of Aβ(1–42) in the presence of short peptides: conformational studies (2008) (21)
Evidence for the involvement of ATP, but not of VIP/PACAP or nitric oxide, in the excitatory effect of capsaicin in the small intestine. (2000) (21)
Radioimmunoassays of tetrahydrocortisone and tetrahydrocortisol in human urine. (1977) (20)
Fibroblasts and lymphocytes from Alzheimer patients are resistant to β-amyloid-induced increase in the intracellular calcium concentration (2002) (20)
Different electrophysiological actions of 24- and 72-hour aggregated amyloid-beta oligomers on hippocampal field population spike in both anesthetized and awake rats (2010) (20)
First principle computational study on the full conformational space of L-proline diamides. (2005) (19)
Behavioral effects of atrial and brain natriuretic peptides in rats (1992) (19)
Effects of cholecystokinin octapeptide and its fragments on brain monoamines and plasma corticosterone (1981) (19)
Simultaneous Changes of Spatial Memory and Spine Density after Intrahippocampal Administration of Fibrillar Aβ 1–42 to the Rat Brain (2014) (19)
Neutral and positively charged new purine tetramer structures: a computational study of xanthine and uric acid derivatives (2011) (18)
Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8. (2003) (18)
Radioimmunological determination of plasma cortisol (1972) (18)
Fibrillar Abeta (1-42) enhances NMDA receptor sensitivity via the integrin signaling pathway. (2010) (17)
The effect of somatostatin, its fragments and an analog on electroconvulsive shock-induced amnesia in rats (1984) (17)
Fibrillar Aβ1-42 enhances NMDA receptor sensitivity via the integrin signaling pathway (2010) (17)
Synthesis of oxytocin antagonists containing conformationally constrained amino acids in position 2. (1999) (17)
The Intersubunit Region of the Influenza Virus Haemagglutinin is Recognized by Antibodies During Infection (1994) (17)
Proteomic study of the toxic effect of oligomeric Aβ1‐42 in situ prepared from ‘iso‐Aβ1‐42’ (2011) (17)
The effects of atrial natriuretic peptide on active avoidance behavior in rats. The role of transmitters (1991) (17)
The effects of atrial natriuretic peptide on electroconvulsive shock-induced amnesia in rats. Transmitter-mediated action (1991) (16)
Effects of cholecystokinin octapeptide sulphate ester and unsulphated cholecystokinin octapeptide on active avoidance behaviour in rats. (1982) (16)
Solvent effect on aggregational properties of β-amyloid polypeptides studied by FT–IR spectroscopy (1999) (16)
Integrin activation modulates NMDA and AMPA receptor function of CA1 cells in a dose-related fashion in vivo (2008) (16)
Distinct subsets of nucleus basalis neurons exhibit similar sensitivity to excitotoxicity (2002) (16)
Regulation of transendothelial transport in the cerebral microvessels: the role of second messengers-generating systems. (1992) (16)
Conformational and functional properties of peptides covering the intersubunit region of influenza virus hemagglutinin. (1992) (16)
Solid-phase synthesis of porcine cholecystokinin-33 in a new resin via FMOC-strategy. (1991) (15)
Differences between normal and alpha-synuclein overexpressing SH-SY5Y neuroblastoma cells after Aβ(1-42) and NAC treatment (2008) (15)
Effects of intracerebroventricular administration of cholecystokinin-octapeptide-sulfate-ester on dopamine, norepinephrine and serotonin contents of different brain structures in rats (1980) (15)
beta-Amyloid excitotoxicity in rat magnocellular nucleus basalis. Effect of cortical deafferentation on cerebral blood flow regulation and implications for Alzheimer's disease. (2000) (15)
Penetratin analogues acting as antifungal agents. (2011) (14)
Effect of oxytocin on acute enkephalin tolerance in mice (1986) (14)
Beta-amyloid(1-42)-induced cholinergic lesions in rat nucleus basalis bidirectionally modulate serotonergic innervation of the basal forebrain and cerebral cortex. (2001) (14)
New small-size peptides modulators of the exosite of BACE1 obtained from a structure-based design (2017) (14)
Somatostatin28(15–28), but not somatostatin28(1–12), affects central monoaminergic neurotransmission in rats (1990) (13)
Conformational dynamics of titin PEVK explored with FRET spectroscopy. (2009) (13)
Radioimmunoassay of free aldosterone and of its 18-oxo-glucuronide in human urine (1972) (13)
Altered response to mirtazapine on gene expression profile of lymphocytes from Alzheimer's patients. (2004) (12)
Haloperidol Attenuates β-Amyloid-Induced Calcium Imbalance in Human Fibroblasts (2004) (12)
Effects of intracerebroventricular injection of Delta Sleep-Inducing Peptide (DSIP) and an analogue on sleep and brain temperature in rats at night (1985) (12)
Protective effect of an orally administered, highly potent somatostatin analog (RC-121) against absolute ethanol-induced hemorrhagic erosions of the rat gastric mucosa. (1989) (12)
Ca(2+)- and Al(3+)-induced conformational transitions of amyloid fragment H-Ile-Ile-Gly-Leu-Met-NH2. (1996) (12)
42. Standardization of specific radioimmunoassays for plasma estrone, estradiol, progesterone and androstenedione (1974) (12)
Lateral mobility of the antagonist-occupied V2 vasopressin receptor in membranes of renal epithelial cells. (1994) (12)
PACAP-(6-38) inhibits the effects of vasoactive intestinal polypeptide, but not PACAP, on the small intestinal circular muscle. (2001) (12)
Novel nontoxic heat shock protein 90 inhibitors having selective antiproliferative effect. (2006) (12)
Structure-activity relationship in the effects of delta-sleep-inducing peptide (DSIP) on rat sleep (1986) (12)
A novel and simple fluorescence method for the measurement of presynaptic vesicular zinc release in acute hippocampal slices with a fluorescence plate reader (2007) (12)
(R)-tert-Butoxycarbonylamino-fluorenylmethoxycarbonyl-glycine from (S)-benzyloxycarbonyl-serine or from papain resolution of the corresponding amide or methyl ester. (2000) (11)
Mechanical manipulation of Alzheimer's amyloid beta1-42 fibrils. (2006) (11)
The inhibition of tail-pinch-induced food intake by cholecystokinin octapeptides and their fragments. (1984) (11)
Depression of rat feeding in familiar and novel environment by sulfated and nonsulfated cholecystokinin octapeptide (1985) (11)
Branched polypeptides as antigens for influenza virus hemagglutinin and T-cell receptor subunits. (1993) (11)
Functional changes in transcriptomes of the prefrontal cortex and hippocampus in a mouse model of anxiety. (2011) (11)
Synthesis and application of a novel, crystalline phosphoramidite monomer with thiol terminus, suitable for the synthesis of DNA conjugates. (2001) (11)
Ab initio studies on the H-bonding of hypoxanthine and DNA bases (2002) (11)
High-performance liquid chromatographic detection of side reactions in peptide synthesis. (1987) (10)
Molecular Study on the Enantiomeric Relationships of Carvedilol Fragment A, 4-(2-Hydroxypropoxy)carbazol, along with Selected Analogues (2003) (10)
Auto‐inhibition of Ca2+/calmodulin‐dependent protein kinase II by its ATP‐binding domain (2001) (10)
Penetratin and Derivatives Acting as Antibacterial Agents (2013) (10)
[The role of chronic brain hypoperfusion in the pathogenesis of Alzheimer's disease--facts and hypotheses]. (2007) (10)
Influence of sulfated and unsulfated cholecystokinin octapeptide on conditioned feeding behaviour in rats (1981) (10)
Vulnerability of small GABAergic neurons to human beta-amyloid pentapeptide. (1998) (10)
Effects of Aβ1−42 fibrils and of the tetrapeptide Pr‐IIGL on the phosphorylation state of the τ‐protein and on the α7 nicotinic acetylcholine receptor in vitro (2005) (10)
Structural and nanomechanical comparison of epitaxially and solution-grown amyloid β25-35 fibrils. (2015) (10)
The effects of sulfated and nonsulfated cholecystokinin octapeptides on electroconvulsive shock-induced retrograde amnesia after. Intracerebroventricular administration in rats (1984) (10)
Folded and unfolded conformations of the ω-3 polyunsaturated fatty acid family: CH3CH2[CH=CHCH2] B[CH2]MCOOH. First principles study (2006) (10)
Exploratory conformational analysis of N-acetyl-L-Tryptophan-N-methylamide. An ab initio study (2003) (9)
New antifungal peptides. Synthesis, bioassays and initial structure prediction by CD spectroscopy. (2010) (9)
Polarographic detection of nitric oxide released from cardiovascular compounds in aqueous solutions. (1998) (9)
In silico study of full length amyloid β 1-42 Tri-& penta-oligomers in solution (2010) (9)
Characterisation of the variation of mouse brain proteome by two-dimensional electrophoresis. (2011) (9)
Computational studies on the binding of β-sheet breaker (BSB) peptides on amyloid βA(1-42) (2001) (9)
Effect of the beta‐sheet‐breaker peptide LPFFD on oriented network of amyloid β25‐35 fibrils (2011) (9)
One-Pot Synthesis of N -Protected β-Chiral Amino Alcohols (2003) (9)
Novel Therapeutic Target for Prevention of Neurodegenerative Diseases: Modulation of Neuroinflammation with Sig-1R Ligands (2022) (8)
Long-term exposition of cells to β-amyloid results in decreased intracellular calcium concentration (2003) (8)
A chapter in the unity of variety—calcium is the sole author? (2004) (8)
Ligand‐Induced Flocculation of Neurotoxic Fibrillar Aβ(1–42) by Noncovalent Crosslinking (2008) (8)
Inhibitory effect of PACAP(6–38) on relaxations induced by PACAP, VIP and non-adrenergic, non-cholinergic nerve stimulation in the guinea-pig taenia caeci (2000) (8)
Novel bradykinin-1 antagonists containing a (1,2,3,4-tetrahydro-isoquinolin-1-yl)acetic acid scaffold. (2008) (8)
Suggested binding mechanism of the HIV-gp120 to its CD4 receptor (1996) (8)
Structure-antifungal activity relationship of His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 and analogues. (2008) (8)
Cerebrovascular Pathology in Hypertriglyceridemic APOB-100 Transgenic Mice (2018) (8)
Influence of cholecystokinin octapeptide sulfate ester on brain monoamine metabolism in rats (2005) (7)
A novel application of the fluorescent dye bis-ANS for labeling neurons in acute brain slices (2011) (7)
Comparative study of sub-micrometer polymeric structures: Dot-arrays, linear and crossed gratings generated by UV laser based two-beam interference, as surfaces for SPR and AFM based bio-sensing (2007) (7)
GluA1 Phosphorylation Alters Evoked Firing Pattern In Vivo (2012) (7)
New Small-Size Antifungal Peptides: Design, Synthesis and Antifungal Activity (2011) (7)
Molecular pathomechanisms of Alzheimer's disease (2003) (7)
Structure-activity studies concerning effect of cholecystokinin octapeptide on passive avoidance behaviour of rats. (1981) (7)
Effect of somatostatin and its fragments on turning behaviour induced by unilateral substantia nigra lesion in the rat. (1984) (7)
Synthesis and preliminary thermodynamic investigation of hypoxanthine- containing peptide nucleic acids (1999) (7)
Effects of nontoxic heat shock protein 90 inhibitor peptide derivatives on reversal of MDR of tumor cells. (2007) (7)
Self-assembly of Alzheimer's Disease-related Amyloid Peptides into Highly Ordered Nanostructures (2006) (7)
The effects of somatostatin and some of its tetrapeptide fragments on ethanol-induced gastric mucosal erosion in rat. (1987) (7)
Inhibition of feeding by the C-terminal tetrapeptide fragment of cholecystokinin in a novel environment (1986) (7)
A modular numbering system of selected oligopeptides for molecular computations: using pre-computed amino acid building blocks (2003) (7)
Synthesis of two peptide scorpion toxins and their use to investigate the aortic tissue regulation (1995) (7)
Changes in brain monoamine levels of rats during cholecystokinin octapeptide-induced suppression of feeding (1984) (7)
Enhanced G‐protein activation by a mixture of Aβ(25–35), Aβ(1–40/42) and zinc (2004) (6)
Exploratory study on the full conformation space of α-tocopherol and its selected congeners (2003) (6)
An ab initio exploratory study of the full conformational space of MeCO-L-threonine-NH-Me (2003) (6)
Predicting the conformational preferences of N-acetyl-4-hydroxy-l-proline-N′-methylamide from the proline residue (2003) (6)
In Vivo Sulfation of Cholecystokinin Octapeptide (1985) (6)
Effects of the Pentapeptide P33 on Memory and Synaptic Plasticity in APP/PS1 Transgenic Mice: A Novel Mechanism Presenting the Protein Fe65 as a Target (2019) (6)
High-performance separation methods in the analysis of a new peptide family: the galanins. (1996) (6)
Epitaxial assembly dynamics of mutant amyloid β25-35_N27C fibrils explored with time-resolved scanning force microscopy. (2013) (6)
Effects of beta-amyloid on cholinergic, cholinoceptive and GABAergic neurons (1998) (6)
Reaction profiling of the MAO-B catalyzed oxidative deamination of amines in Alzheimer's disease (2003) (6)
The effect of atrial natriuretic factor on arginine-8-vasopressin and oxytocin levels in various brain regions and plasma. (2009) (6)
Endothelium‐dependent Vasorelaxant and Anti‐aggregatory Effect and Mechanism of Action of Some Antifibrinogen RGD (Arg‐Gly‐Asp‐containing) Peptides (1998) (6)
Exploring and characterizing the folding processes of Lys- and Arg-containing Ala-based peptides: A molecular dynamics study (2011) (5)
Amyloid peptides: The active center and the possible mechanism of action, starting and maintaining neuronal death (1995) (5)
Multiple treatment potentiates the anticonvulsive activity of cholecystokinin octapeptides (1985) (5)
Effect of haloperidol and risperidone on amyloid precursor protein levels in vivo (2003) (5)
Comparison of HF, HF + MP2, LDA, BLYP, and B3LYP band structures of the homopolypeptides (2004) (5)
Haloperidol attenuates beta-amyloid-induced calcium imbalance in human fibroblasts. (2004) (5)
A new method for the interpretation of dynamics trajectories in the conformational analysis of HIV receptor mutants (1993) (5)
Gas phase conformational basicity of carvedilol Fragment B, 2(S)-1-(ethylamonium)propane-2-ol: An ab initio study on a protonophoretic of oxidative phosphorylation uncoupling (2003) (5)
Effects of Abeta1-42 fibrils and of the tetrapeptide Pr-IIGL on the phosphorylation state of the tau-protein and on the alpha7 nicotinic acetylcholine receptor in vitro. (2005) (5)
Neuroinflammatory processes are augmented in mice overexpressing human heat-shock protein B1 following ethanol-induced brain injury (2021) (5)
Amyloid beta-peptide and its fragments induce acetylcholine release in in vitro basal forebrain tissue slices of rat brain, but do not affect the choline uptake. (1998) (5)
Inhibition of electroshock-induced seizures by cholecystokinin-related peptides in mice. (1987) (5)
Polypeptide and Protein Aggregates with Neurotoxic Properties in Neurodegenerative Disorders: Emphasis on β-Amyloid-Induced Dysfunction of Receptor-Mediated Signal Transduction Pathways (2006) (5)
High-performance liquid chromatographic method for the separation of the optical isomers of γ,γ′-di-tert.-butyl-d,l-γ-carboxyglutamic acid and d,l-γ-carboxyglutamic acid (1995) (5)
Helix and H-bond formations of alanine-based peptides containing basic amino acids (2011) (5)
Effects of cholecystokinin-related peptides on retention of passive avoidance behaviour. (1982) (5)
STANDARDIZATION OF SPECIFIC RADIOIMMUNOASSAYS FOR PLASMA PROGESTERONE, ESTRADIOL, ESTRONE AND ANDROSTENEDIONE (1974) (5)
An ab initio exploratory study on selected conformational features of MeCO-l-Ala-l-Ala-l-Ala-NH-Me as a XxxYyyZzz tripeptide motif within a protein structure (2003) (5)
An ab initio exploratory study on the conformational features of the dipeptide MeCO-Ala-Ala-NH-Me in its four different configurations: determination of the behaviour of D-enantiomer amino acids within a peptide chain (2003) (5)
THE EFFECTS OF SULFATED AND UNSULFATED CHOLECYSTOKININ OCTAPEPTIDE ON BRAIN MONOAMINE CONTENT IN RATS (1981) (5)
DEHYDRATION OF THREONINE ESTERS DURING TOSYLATION (2001) (5)
Synthesis of Peptide Nucleic Acid Monomers (1999) (4)
Tritium and iodine labelling of a gastrin like hexapeptide (1984) (4)
Inhibition of haloperidol-induced catalepsy by cholecystokinin octapeptides after central administration to rats (1985) (4)
Ramachandran backbone potential energy surfaces of aspartic acid and aspartate residues: Implications on allosteric sites in receptor-ligand complexations (2003) (4)
Effect of atrial natriuretic peptide on apomorphine-induced stereotyped cage-climbing behavior in mice. (1992) (4)
Novel High Affinity Sigma-1 Receptor Ligands from Minimal Ensemble Docking-Based Virtual Screening (2021) (4)
Radioimmunoassay of tetrahydrocorticosterone (THB) in human urine. (1978) (4)
Effect of atrial natriuretic peptide on DOPA potentiation in mice (1992) (4)
How to Stabilize Both the Proteins and the Membranes: Diverse Effects of sHsps in Neuroprotection (2015) (4)
Serum butyrylcholinesterase activity in hyperlipidaemia. (2004) (4)
An exploratory conformational analysis of 3-mercapto-propanamide and 2-methyl-3-mercapto-propanamide as well as their S-deprotonated conjugate basis: an ab initio study (2000) (4)
Atrial natriuretic peptide assayed after immunoextraction with magnetic iron particles. (1991) (4)
An Improved Method for the Preparation of ω-Cyclohexyl Esters of Aspartic and Glutamic Acid (1992) (3)
Design, synthesis and potential use of 3,9‐substituted xanthene handles for Solid Phase Peptide Synthesis (1994) (3)
A model study of the IgA hinge region: an exploratory study of selected backbone conformations of MeCO-l-Pro-l-Thr-NH-Me (2003) (3)
Neuroprotective effects of a specific multi-nutrient intervention against Aβ42-induced toxicity in rats (2011) (3)
63 New anticancer peptide analog compounds targeting the tumor HSP90 protein have no toxic effect on normal cells (2005) (3)
Density functional study of infinite polyserine chains. (2005) (3)
Alzheimer's lymphocytes are resistant to ultraviolet B-induced apoptosis (2006) (3)
Mechanism of neurodegeneration and neuroprotection (2003) (3)
Can NO2+ exist in bent or cyclic forms? (2001) (3)
An exploratory ab initio conformational analysis of selected fragments of nicotinamide adenine dinucleotide (NAD+). Part II: adenosine (2003) (3)
Cataleptogenic and anticataleptic activity produced by cholecystokinin octapeptides in mice (1985) (3)
Ab initio calculations on simple heterocycles and DNA base-pair triplets (2003) (3)
Cholecystokinin octapeptides influence tolerance to ethanol in mice (1985) (3)
The Involvement of Nitric Oxide (NO) in the CGRP-Induced Behavior of Rats (1996) (3)
[Synthesis and biological activity of new CCK antagonists]. (1989) (3)
Synthesis and investigation of the β-amyloid 1–42 polypeptide and its analogs (1993) (3)
Immunocytochemical Application to the Central Nervous System 1 (2007) (3)
A new synthesis of Rink's polymer, 4-(2',4'-dimethoxyphenylhydroxymethyl)phenoxymethylpolystyrene . (2009) (3)
Cholecystokinin-destroying activities of canine tissue homogenates. (1986) (3)
Heart-cutting two-dimensional liquid chromatography coupled to quadrupole-orbitrap high resolution mass spectrometry for determination of N,N-dimethyltryptamine in rat plasma and brain; Method development and application. (2020) (3)
Peripheral kynurenine metabolism in focal dystonia. (2007) (3)
Targeted immobilization of neurotransmitters and neuropeptides on agarose and on Acrylex polymers. (1986) (2)
SYNTHESIS OF CHOLECYSTOKININ PEPTIDES (1987) (2)
The triplex forming ability of nonnatural nucleobases: a computational approach (2000) (2)
[The effects of duloxetine on beta-actin stress response in rat brain]. (2010) (2)
Folded and unfolded conformations of the omega-3 polyunsaturated fatty acid family: ch(3)ch(2)[ch=chch(2)](b)[ch(2)](m)cooh: first principles study. (2006) (2)
Epimerization-Free Amidation of Protected Peptide Acids (1995) (2)
Synthesis and cytotoxic activity of 4-N-carboxybutyl-5-fluorocytosyl-Arg-Gln-Trp-Arg-Arg-Trp-Trp-Gln-Arg-NH₂. (2012) (2)
Influence of cholecystokinin on the synaptosomal dopamine uptake in the nucleus accumbens of rats (1987) (2)
Computer-aided design and synthesis of protecting groups and reagents in peptide chemistry (1992) (2)
Comparison and optimization of synthetic methods for preparing cholecystokinin peptides (2009) (2)
S1R agonist modulates rat platelet eicosanoid synthesis and aggregation (2021) (2)
Endogenous neurotransmitters as anti-amigdaloidic agents: a density functional investigation of the interaction between melatonin and histidine (2003) (2)
The Lymphocyte Transformation Test with Sulphadiminidum and with Prealbumin‐Sulphadiminidum Complex in Patients with Drug Allergy (1994) (2)
Competitive mechanisms of basic peptides inducing transganglionic degenerative atrophy. (1988) (2)
Solid phase synthesis of acid-sensitive peptide amides (1988) (2)
An exploratory ab initio conformational analysis of selected fragments of nicotinamide adenine dinucleotide (NAD+). Part I: 5-deoxyribose nicotinamide N-glycoside (2003) (2)
CHANGES OF BRAIN MONOAMINES AFTER INTRACEREBROVENTRICULAR ADMINISTRATION OF THE C-TERMINAL GASTRIN FRAGMENTS IN RATS (1981) (2)
IN VITRO AND IN VIVO NF-Κ B INHIBITORY EFFECTS OF THE CELL-PENETRATING PENETRATIN PEPTIDE (2006) (2)
Aspartic acid scaffold in bradykinin B1 antagonists (2009) (2)
Impact of Two Neuronal Sigma-1 Receptor Modulators, PRE084 and DMT, on Neurogenesis and Neuroinflammation in an Aβ1–42-Injected, Wild-Type Mouse Model of AD (2022) (2)
TRANSGANGLIONIC EFFECT OF BASIC PEPTIDES ON THE PRIMARY NOCICEPTIVE ANALYZER (1986) (2)
Thermally-Induced Effects in Oriented Network of Amyloid β25-35 fibrils (2008) (2)
beta-Amyloid[1-40]-induced early hyperpolarization in M26-1F cells, an immortalized rat striatal cell line. (1999) (1)
Opposite effect of Ca 2 + / Mg 2 + ions on the aggregation of native and precursor-derived A b 42 (2015) (1)
Degradation of cholecystokinin octapeptide by the neutral endopeptidase EC 3.4.24.11 and design of proteolysis-resistant analogues of the peptide (1987) (1)
Peptides : chemistry, biology, interactions with proteins : proceedings of the 50th Anniversary Symposium of the Nobel-Prize of Albert Szent-Györgyi, Szeged, Hungary, August 31-September 4, 1987 (1988) (1)
[Change of fibroblast calcium levels caused by beta-amyloid peptide in Alzheimer disease]. (2002) (1)
The effect of cholecystokinin-octapeptide on striatal dopamine metabolism and on apomorphine-induced behavioral reactions in mice (1980) (1)
Synthesis of phosphotyrosine-containing peptides: Comparison of different methods and their use to investigate cell signalling via the T-cell receptor (1995) (1)
Structure of Titin PEVK Explored with FRET Spectroscopy (2012) (1)
Ring-formation by methylation of phenylserine derivatives (1985) (1)
Effects of sub-chronic, in vivo administration of sigma non-opioid intracellular receptor 1 ligands on platelet and aortic arachidonate cascade in rats. (2022) (1)
EFFECT OF GASTRIN AND GASTRIN FRAGMENTS ON BRAIN MONOAMINES (1980) (1)
ATTEMPTS AT THE SYNTHESIS OF FOLLICLE STIMULATING HORMONE RELEASING PROTEIN (FRP) (1987) (1)
Examination of Longitudinal Alterations in Alzheimer’s Disease-Related Neurogenesis in an APP/PS1 Transgenic Mouse Model, and the Effects of P33, a Putative Neuroprotective Agent Thereon (2022) (1)
One‐Pot Synthesis of N‐Protected β‐Chiral Amino Alcohols. (2003) (1)
A new synthesis of somatostatin and some potential metabolites (1986) (1)
Improved chemical synthesis of optically pure N‐(9‐fluorenyl‐methoxycarbonyl)‐γ,γ′‐di‐tert‐butyl‐γ‐carboxyglutamic acid (1997) (1)
Effect of distinct amyloid β1-42 assemblies on synaptic plasticity (2009) (1)
The effect of cholecystokinin octapeptide sulfate ester on monoamine turnover in different brain regions of rats (1980) (1)
Synthesis of tritium-labelled -amyloid fragments (1998) (1)
SYNTHESIS OF POTENT HEPTAPEPTIDE ANALOGS OF CHOLECYSTOKININ (1984) (1)
Amyloid beta-peptide treatment induces a redistribution of acetylcholinesterase within the enzyme-containing neurons in in vitro tissue cultures. (1998) (1)
Design and synthesis of 3,9-substituted xanthene derivatives: Application for solid-phase synthesis (1993) (1)
A Putative Tetrapeptide Antagonist Prevents /3-Amyloid- Induced Long-Term Elevation of [Ca],- in Rat Astrocytes (2019) (1)
Solid phase synthesis of CCK-33 (1991) (1)
Role of Leu(34)-Met(35) in neurotoxicity caused by human beta-amyloid (1-42) peptide in vitro. (1996) (1)
STUDIES WITH TETRAHYDROCORTISOL (THF), TETRAHYDROCORTISONE (THE) AND TETRAHYDRODESOXYCORTISOL (THS) ANTIBODIES (1975) (1)
Effects of the controlled temperature in the production of high-shear granulated protein-containing granules (2021) (1)
Effect of hydrophilic amino acid substitutions on the solubility and secondary structure of βA (1-42) (1998) (1)
Ac-Gly-Arg-Gly-Asp-Ser-OH, an RGD-peptide,induces endothelium-dependent relaxation in isolated rabbit aorta (1994) (1)
Effects of cholecystokinin-related peptides on self-stimulation behaviour in rats (1988) (1)
Memantine rescues cholinergic neurons from the neurotoxic effects of beta-amyloid (A beta 1-42) (2006) (1)
Separation and determination of D- and L-amino acids by ion exchange column chromatography in the form of diastereomer dipeptides (1990) (1)
Mitochondrial Proteome Changes Correlating with β-Amyloid Accumulation (2016) (1)
Opposite effect of Ca2+/Mg2+ ions on the aggregation of native and precursor-derived Aβ42 (2015) (1)
Comparative study of SP[6–11] and its analogs using simulated annealing (2005) (1)
Substituted benzhydrol derivatives as linkers for solid-phase peptide synthesis (1993) (1)
Pentapeptides derived from A beta 1-42 protect modulatory effect of A beta fibrils - an in vivo electrophysiological study (2005) (1)
Enhanced G-protein activation by a mixture of Abeta(25-35), Abeta(1-40/42) and zinc. (2004) (1)
Effect of Ala-substitution, N- and C-terminal modification and the presence of counter ions on the structure of amyloid peptide fragment 25–35 (2001) (1)
[Improved synthesis of the highly active cholecystokinin sequence succinyl Tyr (OSO3-)-Met-Gly-Trp-Asp-Phe-NH2]. (1987) (1)
P.5.b.005 Memantine rescues cholinergic neurons from the neurotoxic effects of β-amyloid (Aβ1-42) (2006) (1)
Physiological role of amyloid precursor protein (APP) and beta-amyloid peptides (2002) (0)
Hypoxanthine vs. DNA Bases: an Ab Initio Study (2003) (0)
Solid phase synthesis of osteocalcin 14–27 peptide fragment with Fmoc strategy (1995) (0)
A novel anti-inflammatory peptide ameliorates the severity of cholecystokinin-induced acute pancreatitis (2004) (0)
Metabolism of C-terminal pentapeptide of gastrin in the rat. Part IV. Catabolic pathways of the N-terminal BOC-14C-glycine fragment. (1980) (0)
Multi-nutrient intervention in prodromal Alzheimer’s disease: rationale based on results from the lipididiet programme (2016) (0)
Antipsychotics in the treatment of Alzheimer’s disease (2003) (0)
Design, Synthesis and Potential Use of 3,9‐Substituted Xanthene Handles for Solid Phase Peptide Synthesis. (1994) (0)
Computer aided design of triplet forming artificial nucleobases (1999) (0)
University of Groningen β-Amyloid Excitotoxicity in Rat Magnocellular Nucleus Basalis. Effect of Cortical Deafferentation on Cerebral Blood Flow Regulation and Implications for Alzheimer’s Disease Harkany, (2018) (0)
The Active Centres of Gastrin and Cholecystokynin: Syntheses, Conformational Problems, Correlation between Chemical Structure and Biological Activity (1983) (0)
Synthesis & conformational analysis of his-phe-arg-trp-nh2 & analogues with antifungal properties (2010) (0)
Lipid-membrán iskola a Szegedi Biológiai Központban = Lipid-membrane school at the Biological Research Center (2007) (0)
Effects of Cholecystokinin Octapeptides and Their Fragments on the Acquisition and Extinction of Active Avoidance Behavior of Rats (1986) (0)
Online Measurement of Amyloid Plaque Dissolution in Transgenic Mouse and Human Brain Tissue (2006) (0)
Synthesis and in vitro effects of short analogues of β-amyloid peptide on resting transmembrane potential (1999) (0)
[Synthesis of peptide and pseudo-peptide analogs of cholecystokinin]. (1997) (0)
Amyloid-beta: neurotoxic mechanisms and neuroprotective approaches (2005) (0)
Whole Blood Samples from Alzheimer Patients and Control Donors Demonstrate Fluorimetric Differences (2002) (0)
New chapter in skin biopsy: diagnostic tool for neurodegenerative disorders (2008) (0)
Effects of sub-chronic, in vivo administration of sigma-1 receptor ligands on platelet and aortic arachidonate cascade in streptozotocin-induced diabetic rats (2022) (0)
The role of endogenous CRH in the mediation of the neuroendocrine and behavioral response to CCK in rats (1992) (0)
The cytoprotective effect of the desamino-D-Trp 7-10 fragment of somatostatin on ethanol-induced erosions in the rat stomach. (1989) (0)
Forthcoming papers (1999) (0)
Abeta(1-42) induces impairment of LTP and spiking rate in the CA1 (2019) (0)
PAPERS Docking approach of inhibitor design for p-secretase of Alzheimer's disease (2019) (0)
Modulation of the effects of morphine by cholecystokinin in rats (1989) (0)
Comparison of Epitaxially and Solution-Grown Amyloid ß25-35 Fibrils (2012) (0)
Efficient, racemization-free amidation of protected peptide acids with precise stereochemical purity control (1995) (0)
P4-305 Memantine rescues cholinergic neurons from the neurotoxic effects of β-amyloid (Aβ1-42) (2006) (0)
EFFECT OF GASTRIN ANALOGUES ON THE GASTRIN RECEPTOR OF THE STOMACH (1980) (0)
Solution structure of the third helix of Antennapedia homeodomain derivative [W6F,W14F] (2002) (0)
University of Groningen β-Amyloid ( 1-42 )-Induced Cholinergic Lesions in Rat Nucleus Basalis Bidirectionally Modulate Serotonergic Innervation of the Basal Forebrain and Cerebral Cortex (2018) (0)
Autonomic Function (2000) (0)
University of Groningen New small-size peptides possessing antifungal activity (2017) (0)
Biologic activity tests on synthetic cholecystokinin octapeptide sulfate ester (1978) (0)
Novel Approaches in Peptide Synthesis. Chemical Peptide Synthesis (1995) (0)
Synthesis and Solid-Phase Application of a 9-Xanthenyl Handle (2001) (0)
Acetylcholine release induced in vitro by beta-amyloid and its fragments. (1997) (0)
Forthcoming papers (1999) (0)
An improved method for the preparation of Pam resins (1991) (0)
Investigation of the influence of peptide-carrier conjugation on the immunological activity of VP1-peptides of foot-and-mouth disease virus O1-Kaufbeuren. (1990) (0)
Metabolism of C-terminal pentapeptide of gastrin in the rat. Part III. The catabolism of the BOC-pentapeptide and its distribution in the organs. (1979) (0)
[Metabolism of the C-terminal pentapeptide of gastrin in the liver and mesentery of rats. Biliary secretion of labeled glycine pentapeptide]. (1973) (0)
Aged synthetic human amyloid β-peptide 1-42 and related fragments induce direct acetylcholine release from rat basal forebrain tissue slices (1998) (0)
Solution structure of the third helix of Antennapedia homeodomain derivatives (RQIKIWFRKWKK) (2002) (0)
P4-313 Online measurement of amyloid plaque dissolution in transgenic mouse and human brain tissue (2006) (0)
Epitaxial Assembly Kinetics of Mutant Amyloid Beta 25-35 Fibrils (2010) (0)
Solid‐Phase Synthesis of Peptide Amides on a Polystyrene Support Using Fluorenylmethoxycarbonyl Protecting Groups. (1987) (0)
Neuroinflammatory processes are augmented in mice overexpressing human heat-shock protein B1 following ethanol-induced brain injury (2021) (0)
neutralizes aβ-induced memory impairment & toxicity (2018) (0)
Highly Oriented, Functionalized Nanoarray Based on Epitaxially Grown Aß25-35 Fibrils (2012) (0)
[Reasonable synthesis of alpha-L-homoproline and some derivatives. Preparation of 7-alpha-L-homoproline-bradykinin]. (1975) (0)
An Improved Method for the Preparation of ω‐Cyclohexyl Esters of Aspartic and Glutamic Acid. (1992) (0)
Synthesis and investigations of -amyloid peptides and their fragments (1997) (0)
58. Low concentrations of plasma corticosteroids in rabbits immunized with corticotrophin releasing factor (CRF-41) (1982) (0)
OF THE INSTITUTE OF BIOPHYSICS OF THE HUNGARIAN ACADEMY OF SCIENCES 2005 LABORATORY OF MEMBRANE BIOENERGETICS 1 (2011) (0)
Characterization of amino acid-and peptide-conjugated gold and silver nanoparticles (2010) (0)
Oxidative stress contributes to memory impairment and neuronal damage in experimental cerebral hypoperfusion (2007) (0)
GluA 1 Phosphorylation Alters Evoked Firing Pattern InVivo (2014) (0)
Quantum chemical design of new hydrogen‐bond forming heterocyclic molecules suitable for the synthesis of sequence‐specific DNA triplex (2008) (0)
The structure of gastrointestinal hormones. (1976) (0)
Improved Chemical Synthesis of Optically Pure N-(9- Fluorenylmethoxycarbonyl)-γ,γ′-di-tert-butyl-γ- carboxyglutamic Acid. (1997) (0)
Conformational Studies on Synthetic Peptide Models of the Intersubunit Region of Influenza Virus Hemagglutinin (1992) (0)
Synthesis and HPLC Purification of the Renin Substrate Tetradecapeptide. (1988) (0)
Neurodegenerative Disease and Treatments (2003) (0)
Antisera to l '-Aminobutyric Acid . I . Production and Characterization Using a New Model System 1 (2007) (0)
What is the Minimum Active Centre of Gastrin (1983) (0)
Overexpression of Hsp27 ameliorates symptoms of Alzheimer's disease in APP/PS1 mice (2013) (0)
Hormone-receptor studies with the aid of gastrin analogues (1980) (0)
Synthesis and structure investigation of amyloid small peptide fragments (1995) (0)
Penetratin & derivatives acting as antifungal agents (2010) (0)
Synthesis and Tritium Labeling of β‐Amyloid(31‐35) and β‐Amyloid(25‐35) Peptides (2000) (0)
Investigation of behavioural effects of cholecystokinin octapeptides and their fragments: Analysis of mode and site of action (1986) (0)
A new model for the development of Alzheimer’S disease (1994) (0)
Affinity Chromatographic Method for the Extraction of Ocytocin from Human and Rat Plasma (1994) (0)
Solution structure of the third helix of Antennapedia homeodomain (2002) (0)
A new affinity chromatographic method for quantitative extraction and determination of peptide hormones (1993) (0)
New Pathways Identify Novel Drug Targets for the Prevention and Treatment of Alzheimer’s Disease (2023) (0)
Guanine, Xanthine and Uric Acid Assemblies: Comparative Theoretical and Experimental Studies (2012) (0)
Novel Bradykinin‐1 Antagonists Containing a (1,2,3,4‐Tetrahydro‐isoquinolin‐1‐yl)acetic Acid Scaffold. (2008) (0)
Synthesis of ANP and related compounds: The active center of the central effects (1993) (0)
Chemical characterization of a positive inotropic plasma factor in shock. (1989) (0)
Synthesis and characterization of various antigens related to catecholamines (1980) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Botondtól Penke?

Botondtól Penke is affiliated with the following schools:

Botondtól Penke's Academic­Influence.com Rankings

Botondtól Penke's Degrees

Similar Degrees You Can Earn

Why Is Botondtól Penke Influential?

Botondtól Penke's Published Works

Published Works

What Schools Are Affiliated With Botondtól Penke?

Botondtól Penke's AcademicInfluence.com Rankings